Published on in Vol 8, No 5 (2020): May
1 Merck Research Labs Information Technology, Merck Sharpe & Dohme, Prague, Czech Republic
2 Epidemiology, Biostatistics and Prevention Institute, University of Zürich, Zürich, Switzerland
3 Department of Anthropology and Human Genetics, Faculty of Science, Charles University, Prague, Czech Republic
4 Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom
5 Neurology Services, San Raffaele Hospital Multiple Sclerosis Centre, Milan, Italy
6 Department of Engineering and Applied Science, University of Bergamo, Bergamo, Italy
7 National Institute for Health Research, Maudsley Biomedical Research Centre, South London and Maudsley NHS Foundation Trust, London, United Kingdom
8 Patient Advisory Board, Remote Assessment of Disease and Relapse Research Program, King's College London, London, United Kingdom
9 Merck Research Labs Information Technology, Merck Sharpe & Dohme, Singapore, Singapore
10 Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Merck & Co, Inc, Kenilworth, NJ, United States
11 Department for Neurosciences, Center for Contextual Psychiatry, Katholieke Universiteit Leuven, Leuven, Belgium
12 Janssen Pharmaceutica NV, Beerse, Belgium
13 Research and Development Information Technology, Janssen Research & Development, LLC, Titusville, NJ, United States